回到 StockQ 正常版首頁 |
首域盈信中國核心基金
| ||||||||||||
年度報酬率 |
2020 | 2021 | 2022 | 2023 | 2024 |
26.66% | -14.11% | -17.09% | -23.62% | 7.76% |
首域盈信中國核心基金 基金資料 |
本基金為一項由在中國大陸成立或擁有重大業務之大型及中型企業組成的集中投資組合,發行該等證券的企業於全球受監管市場上市、買賣或交易。 |
日期 | 淨值 | 漲跌比例 |
2025/04/24 | 9.6538 | -0.71% |
2025/04/23 | 9.7224 | 1.76% |
2025/04/22 | 9.5540 | -0.54% |
2025/04/17 | 9.6063 | 0.96% |
2025/04/16 | 9.5150 | -1.50% |
2025/04/15 | 9.6602 | 0.33% |
2025/04/14 | 9.6282 | 1.13% |
2025/04/11 | 9.5203 | 0.65% |
2025/04/10 | 9.4585 | 2.32% |
2025/04/09 | 9.2436 | 1.00% |
名稱 | 三個月 | 六個月 | 一年 | 今年 |
首域盈信中國核心基金/美元 | 5.35% | -3.57% | 7.40% | 2.31% |
上海綜合指數 | 1.37% | 0.52% | 8.29% | -1.63% |
上海A股指數 | 1.37% | 0.51% | 8.26% | -1.64% |
上海B股指數 | -4.01% | -6.58% | 3.53% | -4.69% |
深圳A股指數 | 10.64% | 7.76% | 24.82% | 5.87% |
深圳B股指數 | 5.71% | 10.87% | 36.76% | 9.83% |
深證成指 | 9.17% | 6.76% | 26.43% | 4.78% |
中小板指指數 | 10.10% | 5.58% | 23.44% | 3.66% |
創業板指指數 | 25.47% | 19.88% | 42.61% | 17.22% |
滬深300指數 | 2.54% | 2.16% | 25.46% | 0.24% |
香港恆生指數 | 9.19% | 6.93% | 27.37% | 9.22% |
香港國企指數 | 10.18% | 9.48% | 32.07% | 10.52% |
香港紅籌指數 | 4.87% | -2.82% | 5.99% | -0.41% |
MSCI 中國指數 (price) | 9.67% | 5.47% | 24.68% | 9.17% |
聯博中國A股基金-A2類型/台幣 | -2.86% | -6.81% | 1.61% | -3.84% |
聯博中國A股基金-A2類型/美元 | -2.01% | -7.97% | 1.87% | -3.00% |
聯博中國A股基金-A2類型/人民幣 | -2.05% | -6.08% | 2.24% | -3.65% |
聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
安聯中國股票基金-A股/配息/美元 | 7.55% | 0.91% | 16.95% | 7.14% |
安聯中國策略基金/台幣 | -4.88% | -6.76% | 4.78% | -4.31% |
霸菱香港中國基金-A類/配息/歐元 | 0.31% | -4.86% | 9.58% | -1.74% |
霸菱香港中國基金-A類/配息/美元 | 9.72% | 0.25% | 16.63% | 7.41% |
霸菱香港中國基金-A類/配息/英鎊 | 1.54% | -2.23% | 9.07% | 1.27% |
貝萊德中國基金A2/美元 | 5.35% | 1.45% | 18.93% | 5.22% |
貝萊德中國基金A2-歐元避險 | 4.39% | -0.08% | 15.99% | 3.97% |
貝萊德中國基金A2-澳幣避險 | 4.01% | -0.16% | 15.44% | 3.59% |
法巴中國股票基金-C股/美元 | 11.60% | 5.56% | 27.32% | 10.62% |
群益華夏盛世基金/台幣 | -3.15% | -6.22% | -0.74% | -5.98% |
群益中國新機會基金/台幣 | -4.93% | -7.63% | -3.89% | -6.52% |
群益中國新機會基金/美元 | -4.19% | -8.80% | -3.66% | -5.75% |
群益華夏盛世基金/美元 | -2.29% | -7.41% | -0.44% | -5.15% |
群益華夏盛世基金/人民幣 | -2.22% | -5.37% | 0.10% | -5.47% |
群益中國新機會基金/人民幣 | -4.12% | -6.79% | -3.14% | -6.08% |
DWS投資中國股票基金A2/美元 | 6.82% | 3.20% | 19.96% | 7.38% |
DWS投資中國股票基金E2/美元 | 7.04% | 3.66% | 21.01% | 7.68% |
DWS投資中國股票基金LC/歐元 | -1.44% | -1.92% | 12.97% | -1.73% |
DWS投資中國股票基金FC/歐元 | -1.26% | -1.53% | 13.87% | -1.49% |
瀚亞中國股票基金/美元 | 9.36% | 4.72% | 21.18% | 9.68% |
瀚亞中國基金/台幣 | -1.03% | -7.85% | -1.98% | -4.30% |
愛德蒙得洛希爾中國基金(A)/歐元 | 0.40% | -2.98% | 21.42% | -2.62% |
愛德蒙得洛希爾中國基金(A)/美元 | 9.61% | 2.20% | 28.83% | 6.73% |
歐義銳榮中國股票基金-R2/美元 | 11.03% | 3.68% | 27.53% | 9.11% |
歐義銳榮中國股票基金-R/歐元 | 1.71% | -1.57% | 20.21% | -0.45% |
富達中國聚焦基金/美元 | 7.72% | 2.22% | 9.89% | 6.05% |
富蘭克林華美中國消費基金/台幣 | -3.67% | -6.63% | 2.16% | -4.16% |
富蘭克林華美中國傘型基金之中國A股基金/台幣 | -5.04% | -7.93% | -0.12% | -5.89% |
富蘭克林華美中國傘型基金之中國A股基金/人民幣 | -4.16% | -7.20% | 0.53% | -5.70% |
富蘭克林華美中國傘型基金之中國A股基金/美元 | -4.31% | -9.17% | 0.12% | -5.08% |
復華華人世紀基金/台幣 | -9.80% | 2.03% | 15.34% | -3.68% |
復華大中華中小策略基金/台幣 | -18.65% | -19.89% | -5.39% | -18.02% |
匯豐中國動力基金-台幣 | -2.22% | -6.22% | 6.64% | -4.34% |
匯豐中國股票基金AD/美元 | 9.49% | 3.67% | 16.63% | 7.55% |
景順中國基金-A股/美元 | 5.74% | 2.38% | 15.62% | 5.30% |
景順中國基金-A股/歐元對沖 | 5.47% | 1.29% | 13.13% | 4.77% |
景順中國基金-A股/澳幣對沖 | 5.19% | 1.40% | 12.95% | 4.68% |
摩根中國基金-A股/分派/美元 | 4.47% | -1.50% | 14.26% | 3.82% |
木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
木星中國基金–ACC/英鎊 | 6.23% | 10.28% | 26.47% | 5.26% |
野村中國機會基金/台幣 | -0.71% | -5.09% | 0.40% | 0.08% |
鋒裕匯理-中國股票基金-A2/美元 | 4.02% | 1.70% | 14.13% | 5.29% |
鋒裕匯理-中國股票基金-B2/美元 | 3.90% | 1.36% | 13.36% | 5.16% |
鋒裕匯理-中國股票基金-A2/歐元 | -3.75% | -3.44% | 7.28% | -4.05% |
荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
新光中國成長基金/台幣 | -1.68% | -3.30% | 4.35% | -1.68% |
瑞銀(盧森堡)中國精選股票基金/美元 | 11.58% | 4.12% | 18.41% | 9.28% |
瑞銀(盧森堡)中國精選股票基金-月配息/美元 | 11.04% | 3.07% | 16.03% | 8.56% |
元大新中國基金/台幣 | -6.19% | -7.71% | -2.00% | -4.19% |
| ||||||||||||
StockQ 全球股市指數 © All rights reserved.
|